APOE and atherosclerosis: Similarly, previous studies have shown that dietary supplementation with ∼0.1% tomatidine for 2 weeks is safe in pregnant and non-pregnant mice (31), and dietary supplementation with ∼0.04% tomatidine for 10 weeks reduces plasma cholesterol and atherosclerosis in ApoE-deficient mice without evidence of toxicity (32).